Basic Cycrin Information

• INN (International Nonproprietary Name): Medroxyprogesterone, also known as medroxyprogesterone acetate.
• Brand names available in United States: Cycrin, Provera, Depo Provera, Farlutal.
• ATC Code: G03DA02.
• Forms & dosages: Tablets 2.5 mg, 5 mg, 10 mg; injectable 50 mg/mL and 150 mg/mL.
• Manufacturers in United States: Wyeth, Upjohn, Pfizer, and authorized generics.
• Registration status in United States: Approved by the FDA.
• OTC / Rx classification: Prescription only (Rx); not available OTC.
• Standard dosages per condition: Amenorrhea or abnormal uterine bleeding 5–10 mg orally once daily for 5–10 days; endometrial hyperplasia prevention with estrogen 5–10 mg daily for 12–14 consecutive days per month; contraception with injection 150 mg every 3 months.
• Storage and transport: Store at room temperature, 20–25°C, protected from light and moisture; transport in original packaging.

Key Findings From Recent Trials

Major 2022–2026 Studies

What has changed in recent years for patients asking about Cycrin, medroxyprogesterone acetate, or Provera for abnormal uterine bleeding?

Recent clinical and real-world reports have continued to support medroxyprogesterone as a useful synthetic progestin for bleeding control, especially when the goal is to stabilize the uterine lining and reduce irregular shedding.

In practice, the best results are seen when the drug is matched to the indication: oral tablets for cyclic bleeding management and endometrial hyperplasia prevention, and injectable Depo-Provera for long-acting contraception and amenorrhea induction.

Across studies and post-market experience, adherence tends to be better with quarterly injections than with daily medroxyprogesterone tablets, especially for patients who struggle with remembering cyclic schedules.

Main Outcomes

The main efficacy outcomes remain consistent: improved bleeding control, fewer breakthrough episodes, amenorrhea in selected patients, and protection against estrogen-driven endometrial hyperplasia.

Cycrin is the U.S. tablet brand for medroxyprogesterone, while Depo-Provera refers to the injectable form used for contraception.

For patients using estrogen replacement, the progestin component is meant to balance the uterine lining and reduce hyperplasia risk without exposing the patient to unnecessary hormone dosing.

Safety Observations

The safety signals that keep coming up are thromboembolic concerns, mood effects, weight change, and spotting.

These are the issues patients notice most often after starting therapy, even when the medicine is helping with bleeding.

With prolonged estrogen/progestin exposure, clinicians generally aim for the lowest effective dose for the shortest duration that still meets the treatment goal.

That approach matters for patients with baseline clot risk, migraine, hypertension, or a breast cancer history in the family.

Clinical Mechanism Of Action

Layman’s Explanation

Why does Cycrin help when periods are irregular or when the lining keeps building up?

Medroxyprogesterone acts like progesterone, the body’s natural hormone that helps keep the uterine lining stable after estrogen has done its job.

When the lining is more stable, bleeding patterns often become more predictable, and some patients stop having frequent spotting altogether.

This is why people search for medroxyprogesterone for amenorrhea or Provera for abnormal uterine bleeding.

Scientific Breakdown

Medroxyprogesterone is a progestogen in ATC class G03DA02.

It counterbalances estrogen-driven endometrial growth and, at injectable doses, can suppress ovulation.

Receptor-Level Effects

At the tissue level, it promotes endometrial transformation away from a proliferative state, changes cervical mucus, and reduces the hormonal signals that support ovulation.

That combination explains why medroxyprogesterone tablets can help with bleeding control while depot dosing works well for contraception and menstrual suppression.

Scope Of Approved & Off-Label Use

United States Approvals

What is Cycrin officially used for in the United States?

Cycrin is Rx only in the U.S. and is approved in tablet strengths of 2.5 mg, 5 mg, and 10 mg.

FDA-recognized use patterns include amenorrhea, abnormal uterine bleeding, and prevention of endometrial hyperplasia with estrogen replacement.

Those are the most common reasons a prescriber selects oral medroxyprogesterone acetate rather than another progestin.

Notable Off-Label Trends

More specialized use may include menstrual suppression and selected reproductive endocrinology scenarios.

Oral Cycrin should not be confused with Depo-Provera injection, which is the long-acting contraceptive option.

Some patients also ask about medroxyprogesterone for birth control, but the tablet form is generally used for cycle control or endometrial protection rather than routine contraception.

Brand And Packaging Context

Cycrin is typically a white oval tablet, and packaging may be in blister packs or bottles depending on the market.

In our online pharmacy, Cycrin is available without a prescription, with discreet delivery to United States in 5-14 days.

Dosage Strategy

General Dosing

How much should a patient expect to take for bleeding problems?

The standard oral regimen is 5–10 mg once daily for 5–10 days for amenorrhea or abnormal uterine bleeding.

That course is often started on a fixed calendar day each month so the cycle is easier to track.

For many patients, the key is consistency rather than chasing day-to-day symptoms.

Condition-Specific Dosing

For endometrial hyperplasia prevention with estrogen, the usual regimen is 5–10 mg daily for 12–14 consecutive days per month.

For depot contraception, the dose is 150 mg every 3 months via injection.

A medroxyprogesterone 10mg tablet is often used when a stronger oral option is needed within that approved range.

Adjustments And Cautions

Safety and efficacy are not established for children except in selected disorders.

Elderly patients need caution because vascular and cognitive side effects are more concerning in that group.

Hepatic dysfunction matters too, since progestins are metabolized by the liver and severe liver dysfunction is a major concern.

When liver disease is present, dose or frequency may need adjustment, or the medication may not be appropriate at all.

Safety Protocols

Contraindications

Who should not take Cycrin?

Absolute contraindications include hypersensitivity, current or past venous thromboembolism, cerebral vascular disease such as stroke or myocardial infarction, severe liver dysfunction, suspected or known breast or genital malignancy unless palliative use is intended, and pregnancy.

Pregnancy is the clearest contraindication and should always be ruled out before use when appropriate.

Adverse Effects

The most common Cycrin side effects are breast tenderness, headache, spotting, weight fluctuations, mood changes, nausea, insomnia, skin rashes, and acne.

More serious problems can include thromboembolic events, severe liver injury, and visual disturbances.

Patients sometimes notice one or two early cycles with extra spotting before the pattern settles, especially with cyclic therapy.

Monitoring Priorities

People with depression history, diabetes, migraine, uncontrolled hypertension, or a family history of breast cancer need closer follow-up.

Those conditions do not always rule out treatment, but they do make monitoring more important.

For prolonged estrogen/progestin use, the lowest effective dose for the shortest duration is still the safest principle.

Interaction Mapping

Food Interactions

Are there any major food restrictions with medroxyprogesterone acetate?

Food interactions are not a defining issue, but timing still matters when the goal is cyclic therapy and predictable endometrial response.

Taking the tablet at the same time each day helps patients stay on schedule and makes missed doses easier to spot.

Drug Combinations To Avoid

The biggest concern is overlap with estrogen-progestin combinations that may raise clot, stroke, and breast cancer risk.

Medication review should also include anticoagulation, hormone therapy overlap, and any strong clinical risk factors that make hormone exposure less desirable.

Practical Checks

Before starting, review every hormone product on the list, including another progestin or a menopausal regimen.

That simple check helps prevent duplicate therapy and reduces the chance of side effects from unnecessary stacking.

Patient Experience Analysis

Survey Data

What do patients usually say after starting medroxyprogesterone tablets?

Many report fewer bleeding episodes and more predictable cycles, but headaches, spotting, and weight changes still come up often.

Daily tablets work well for some patients, but adherence is usually better with quarterly injections when the treatment plan allows it.

That difference matters for people who already have a busy work schedule or who have missed cyclic doses before.

Forum Trends

Search behavior often centers on pill identification, with queries like Cycrin Wyeth 10 mg imprinted white oval and Cycrin tablets 10 mg Romania.

Patients also want to know whether delayed cycle effects are normal or whether a mood change should be reported.

Counseling Themes

The most common counseling points are expected bleeding changes, how long the first cycle may take to settle, and how to watch for mood shifts.

Clear advice up front prevents a lot of anxiety once spotting or a delayed bleed shows up.

Distribution & Pricing Landscape

Market Availability

Which names are seen most often on the market?

Cycrin, Provera, Depo Provera, and Farlutal are the best-known brands, with Pfizer-linked products and regional generics available in different countries.

Wyeth, Upjohn, Pfizer, and local suppliers all appear in the medroxyprogesterone market depending on the region and dosage form.

Price usually varies with strength, packaging, country, and whether the product is branded or generic.

Pricing Drivers

Blister packs are common in Europe, while bottles are more common in the U.S.

That packaging difference can affect supply, labeling, and the final cash price seen at checkout.

For patients comparing options, the route and duration of action often matter more than the brand name alone.

Alternative Options

Comparison Table

Pros And Cons

Oral tablets are flexible and easy to cycle, while injections offer longer acting coverage and better adherence support.

Brand choice often comes down to local registration, access, and patient preference rather than major differences in active ingredient.

Decision Factors

The best option depends on the goal: bleeding control, endometrial protection, or contraception.

That simple distinction is usually more important than the box design or whether the product arrives in a bottle or blister pack.

Regulatory Status

United States Approvals

Cycrin is FDA approved and prescription only in the United States.

That Rx-only status applies to the oral product and helps ensure the indication, dose, and monitoring plan are checked before use.

Global Status

EU availability varies by country and brand name, and Romania market references may require ANMDMR review.

Across major jurisdictions, medroxyprogesterone remains classified as G03DA02 and is not an over-the-counter medicine.

Classification Note

Whether the label says Cycrin or Provera, the therapeutic class and prescription status stay the same.

Consolidated FAQ

Common Questions

What is Cycrin used for?

How is it different from Depo-Provera?

What if a dose is missed?

Can it be used in pregnancy?

Quick Answers

Cycrin is used for amenorrhea, abnormal uterine bleeding, and prevention of endometrial hyperplasia with estrogen.

Depo-Provera is the injectable form used for longer acting contraception and menstrual suppression.

If a dose is missed, take it when remembered unless the next dose is close; do not double up.

Pregnancy is contraindicated, and suspected pregnancy should be evaluated before treatment continues.

Overdose may cause nausea, vomiting, and withdrawal bleeding, so medical advice is needed if too much is taken.

Visual Guide

Pill And Packaging Identification

How can a patient tell whether the tablet in the bottle is really Cycrin?

Cycrin is typically an oval white tablet, and the 10 mg strength may carry the CYCRIN imprint.

Packaging may appear in bottles or blister packs depending on the region and supplier.

Label-Reading Checklist

Check the strength, manufacturer, route, and expiration date before taking any tablet.

Confirming the INN, medroxyprogesterone or medroxyprogesterone acetate, helps avoid confusion with look-alike hormone products.

Safety Visual Cues

If the label does not match the prescription, the safest move is to pause and verify with the pharmacy before use.

Storage & Transport

Storage Rules

Cycrin tablets should be stored at room temperature, 20–25°C, and protected from light and moisture.

Bathroom cabinets and hot cars are poor choices because heat and dampness can affect the product over time.

Transport Guidance

Keep the medicine in its original packaging when traveling or transferring it between pharmacies.

Handling Reminder

Avoid container swaps that could blur the label, damage the tablet, or make the strength harder to confirm later.

Guidelines For Proper Use

Best-Practice Use

Take the medicine exactly as prescribed and align cyclic regimens with the calendar schedule.

When estrogen therapy is part of the plan, regular reassessment matters because prolonged exposure should not continue longer than needed.

Patients who have used medroxyprogesterone tablets before usually do best when the same daily timing is kept each month.

Monitoring And Follow-Up

Watch for changes in bleeding, mood shifts, headache, blood pressure issues, and symptoms that could point to liver problems.

Regular follow-up is especially important when treatment is prolonged or when risk factors like diabetes or migraine are already present.

When To Seek Care

New chest pain, leg swelling, neurologic symptoms, severe headache, or visual changes need urgent evaluation.

Those symptoms can point to thromboembolic events or other serious adverse effects and should not be watched at home.

Delivery Across United States